Friday, December 5, 2014

Today's Datapoint


$18 billion is the projected total of patent expirations for brand-name pharmaceuticals in 2014, with $21 billion projected for 2015 and $22 billion in 2016, according to Chris Peterson, Pharm.D., a director in the Emerging Therapeutics department at Express Scripts Holding Company.

No comments:

Post a Comment